Rapid Micro Biosystems (RPID) EBT (2020 - 2026)

Rapid Micro Biosystems has disclosed EBT across 7 years of filings, most recently posting -$14.3 million for Q1 2026.

• EBT for Q1 2026 came in at -$14.3 million, down 26.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$50.1 million (down 11.81% YoY), and the FY2025 annual result was -$47.1 million, changed 0.46% from the prior year.
• EBT came in at -$14.3 million for Q1 2026 at Rapid Micro Biosystems, down from -$12.5 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$9.7 million in Q4 2024 to a low of -$16.4 million in Q4 2022.
• The 5-year median for EBT is -$13.3 million (2024), against an average of -$13.1 million.
• Across the five-year window, EBT jumped 34.59% in 2022 and dropped 29.02% in 2025, its largest moves.
• Rapid Micro Biosystems' EBT stood at -$16.4 million in 2022, then soared by 32.09% to -$11.2 million in 2023, then grew by 13.34% to -$9.7 million in 2024, then decreased by 29.02% to -$12.5 million in 2025, then slipped by 14.29% to -$14.3 million in 2026.
• The last three EBT figures came in at -$14.3 million (Q1 2026), -$12.5 million (Q4 2025), and -$11.5 million (Q3 2025), per Business Quant data.